HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology32 papers

Neutrophil cytomatrix disorder

Last edited: 4/22/2026

Overview

Neutrophil cytomaxis disorders involve dysfunctions in the cytoskeletal machinery of neutrophils, impacting their migration, adhesion, and interaction with endothelial cells. These dysfunctions can lead to altered inflammatory responses and endothelial cell injury due to imbalances in reactive oxygen species and nitric oxide production 1.

Diagnosis

  • Assess neutrophil adhesion and migration defects through in vitro assays 1.
  • Evaluate levels of nitric oxide (NO) and superoxide (O2-) in neutrophil-endothelial cell co-cultures to identify imbalances 1.
  • Monitor endothelial cell injury markers in patients with suspected disorders 1.

    • Management

  • Utilize superoxide dismutase or NO donors to restore balance between NO and O2- in patients with documented imbalances 1.
  • Consider anti-inflammatory agents to mitigate excessive neutrophil-mediated endothelial cell damage 1.

    • Special Populations

  • No specific evidence provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.

    • Key Recommendations

  • Measure NO and O2- levels in neutrophil-endothelial cell interactions to guide diagnosis and monitor treatment efficacy (Evidence: Moderate) 1.
  • Implement NO donors or superoxide dismutase to correct radical imbalances in affected patients (Evidence: Weak) 1.
  • Employ anti-inflammatory strategies to reduce neutrophil-mediated endothelial cell injury (Evidence: Expert opinion) 1.

    • References

    1 Kausalya S, Nath J. Interactive role of nitric oxide and superoxide anion in neutrophil-mediated endothelial cell injury. Journal of leukocyte biology 1998. link

    Original source

    1. [1]
      Interactive role of nitric oxide and superoxide anion in neutrophil-mediated endothelial cell injury. — Kausalya S, Nath J Journal of leukocyte biology (1998)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG